108. Prevalence of bleeding disorders in adolescents presenting with heavy menstrual bleeding and anemia

Ozlem Dural,Ipek Evruke,Hevra Ekin Ulusoy,Hilal Seda Saygili,Inci Sema Tas,Cenk Yasa,Funda Gungor Ugurlucan,Suleyman Engin Akhan
DOI: https://doi.org/10.1016/j.jpag.2024.01.115
IF: 2.046
2024-04-04
Journal of Pediatric and Adolescent Gynecology
Abstract:Background Heavy menstrual bleeding (HMB) is one of the most common gynecologic disorders among adolescents. While anovulatory bleeding (AB) is usually the underlying cause, a previously undiagnosed bleeding disorder (BD) can also may also lead to such bleeding. It has been reported that approximately 20% of adolescents with HMB and up to 33% of girls hospitalized for HMB may have BD. The aim of our study was to investigate the prevalence of BD in a population of adolescents who were evaluated for HMB and whose hemoglobin values were 12 and below Methods We retrospectively reviewed medical records of 137 adolescents aged 10 to 18 years who were presented with HMB to a tertiary Pediatric and Adolescent Gynecology Service between July 2017 and September 2023 and had hemoglobin values of 12 g/dL and below. Data on medical history, menstrual history, bleeding symptoms, gynecologic evaluation, hospitalization, blood transfusion, treatments, and screening for BD were evaluated. Results A total of 137 adolescents with HMB met the inclusion criteria. The mean age at the onset of symptoms and at menarche 14±1.9 years and 12.1±1.3 years, respectively. A history of previously diagnosed BD or a medical condition that could cause BD was identified in 14 patients. The mean hemoglobin value on presentation was 8.1±2.2 g/dL. The rate of hospitalization for management was 51% (70/137) and 44 patients (32.1%) received packed red blood cell transfusions. Evaluation for the presence of a bleeding disorder was performed in 106/123 (%86.1) of the patients. Overall, 9 adolescents were diagnosed with some underlying BD, giving a prevalence of 9/106 (8.4%) in those screened for BD (Table 1). Among these 9 patients, von Willebrand disease was the most common BD (55%). When all patients are divided into two groups as those with an initial Hb value of 8 or less (Group 1) and those with a Hb value between 8 and 12 (Group 2), 5.5% of patients in Group 1 (3/55) and 11.7% in Group 2 (6/51) had a coagulation disorders, with no statistically significant difference (Table 2). Conclusions In this age group, anovulatory bleeding alone may cause severe anemia required inpatient hospital stays and blood transfusion needs. Timely initiation of hormonal suppression in these cases is important to reduce these negative consequences. According to our findings, the rate of detection of BD was 8.4% in the adolescents presented with HMB. The fact that the detection rate of BD was found to be higher in adolescents who presented with a more chronic bleeding complaint and mild anemia suggested that BD screening should be performed with the same care in this group.
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?